Mom Multi Postnatal Supplementation Trial
Perelel Inc. · with University of Georgia · NCT07303595
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · Women only
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Not applicable
- Target enrollment
- 80
- US sites recruiting
- 1
- Study start
- November 10, 2025
- Record last updated
- December 26, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to learn if a vitamin and mineral supplement designed specifically for women after childbirth can improve their nutrition and health in women who are pregnant or have recently given birth (within 6 weeks).
The main question it aims to answer is
Can a postpartum-specific vitamin and mineral supplement help improve nutritional status and health outcomes in women after giving birth?
Researchers will compare women who take the new postpartum vitamin and mineral supplement to women who take a placebo (fake pills without active ingredients) to see if the supplement improves their nutritional health.
Participants will
Attend 2 visits at University of Georgia (1-1.5 hours each) over 12 weeks Participate in 2 phone calls between visits Stop taking other vitamin/mineral supplements during the study Have blood drawn to test vitamin and mineral levels Provide urine samples and breastmilk samples if breastfeeding (optional) Have height, weight, and skin color measured Complete questionnaires about health, pregnancy, and mental wellness Answer questions about daily food and drink intake Take either the study supplement or placebo daily
Being studied: Perelel Mom Multi; Placebo
Conditions: Postnatal Care
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion criteria
- Healthy, postpartum women (\~4 weeks [± 2 weeks]) with infants born term and singleton
- Not pregnant during the study period
- Able to understand (written and spoken) English or Spanish.
Exclusion criteria
- Cardiometabolic disease
- Past pregnancy complications (gestational diabetes, hypertension)
- malabsorption syndromes (IBS, IBD, Crohn's, Colitis, Celiac)
- Caily use of medications which may affect nutrient absorption
- chronic alcohol use (> 4 alcoholic drinks/day)
- those prescribed postnatal MVM supplements by their physician
- unwilling to discontinue dietary supplementation containing any of the active components in the study product over the study period
- Women should not have an allergy or intolerance to active or inactive product ingredients.
Recruiting US locations
UGA Clinical & Translational Unit
Athens, GA 30606
Site contact: Sina Gallo, PHD · 706-713-2721 · ctru@uga.edu
Study contacts (from the official record)
- Sina Gallo, PhD, MSc, RD · 706-542-4847 · ctru@uga.edu
Similar studies in Georgia
All nutrition & metabolism studies in Georgia →- RecruitingHealthy volunteers
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Cleerly, Inc.
- Location
- Augusta, GA + 121 other US sites
- Eligibility basics
- Ages 55+
- RecruitingPhase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Hoffmann-La Roche
- Location
- Athens, GA + 121 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Hoffmann-La Roche
- Location
- Athens, GA + 112 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 4
Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients
Fresenius Kabi
- Location
- Atlanta, GA + 3 other US sites
- Eligibility basics
- Ages 1 mo–17